News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Teleflex Incorporated (TFX) Completes Previously Announced Acquisition Of Vidacare Corporation



12/3/2013 6:57:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Teleflex Completes Previously Announced Acquisition of Vidacare Corporation

LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, announced today that it has completed the previously announced acquisition of Vidacare Corporation, the leading provider of intraosseous, or inside the bone, access devices.

Based on the date of closing, the acquisition is not expected to significantly impact Teleflex’s 2013 revenue or adjusted earnings per share expectations. The transaction is expected to contribute approximately $68 million to $72 million of revenue and approximately $0.10 to $0.15 in adjusted earnings per share in fiscal year 2014, excluding non-recurring purchase accounting items and other acquisition and integration related costs.

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,200 people worldwide and serves healthcare providers in more than 140 countries. For additional information about Teleflex please refer to http://www.teleflex.com.

Forward-Looking Information

This press release contains forward-looking statements, including, but not limited to, statements relating to the expected accretive effects of the transactions with respect to Teleflex’s adjusted earnings per share results for 2013 and 2014. Actual results could differ materially from those in these forward-looking statements due to, among other things, unexpected expenditures in connection with the effectuation of the acquisitions; costs and length of time required to comply with legal requirements and regulatory approvals applicable to certain aspects of the transactions, unanticipated difficulties in connection with customer reaction to the transactions; and other factors described in Teleflex's filings with the Securities and Exchange Commission.

Contact:

Teleflex Incorporated

Jake Elguicze

Treasurer and Vice President of Investor Relations

610-948-2836

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES